Health
Rapid development of functionally diverse SARS-COV-2 mouse monoclonal antibodies – News-Medical.Net
Now, a recent study published on the preprint server bioRxiv in October 2020 reports the development of a rapid process for generating high-affinity mouse mAbs,…
With the resurgence of the COVID-19 pandemic looming large in many parts of the world, the need for immunological tools such as monoclonal antibodies (mAbs) is more urgent, whether for diagnosis, treatment, or research on the virus. Now, a recent study published on the preprint server bioRxiv* in October 2020 reports the development of a rapid process for generating high-affinity mouse mAbs, and their functional attributes.
The RBD in SARS-CoV-2 Immunology
The focus of most antibody developmen…
-
General16 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business16 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General17 hours agoToo skewed, too gentlemanly | The Spectator Australia
-
General19 hours agoAlbanese beats drum on economy as trade clouds gather